| 000 | 01198 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516035200.0 | ||
| 264 | 0 | _c20110919 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlock, Matthew S | |
| 245 | 0 | 0 |
_aClinical hypothyroidism in a renal cell carcinoma patient treated with sorafenib. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cApr 2011 |
||
| 300 |
_a335-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothyroidism _xchemically induced |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xadverse effects |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aThyroxine _xtherapeutic use |
| 700 | 1 | _aKohli, Manish | |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 9 _gno. 4 _gp. 335-8 |
|
| 999 |
_c20822170 _d20822170 |
||